Marseille
France
25
2019-01-31
20
2020-12-22
These are the the leading inventors for applications assigned to Innate Pharma:
Innate Pharma based in Marseille, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Neutralization of inhibitory pathways in lymphocytes
#2 | 2017-10-19 ✅ Patent 10,676,523 granted on 2020-06-09Treatment regimens using anti-NKG2A antibodies
#3 | 2017-06-08 ✅ Patent 10,280,222 granted on 2019-05-07Humanized antibodies with increased stability
#4 | 2016-02-18 ✅ Patent 9,708,403 granted on 2017-07-18KIR-binding agents and methods of use thereof
#5 | 2015-06-18 ✅ Patent 9,427,478 granted on 2016-08-30Enzymatic conjugation of polypeptides
#6 | 2015-05-21 ✅ Patent 9,944,712 granted on 2018-04-17TLR3 binding agents
#7 | 2014-08-21NKP46-MEDIATED NK CELL TUNING
#8 | 2014-08-21COMPOSITIONS AND METHODS FOR DETECTING TLR3
#9 | 2014-03-06TLR3 BINDING AGENTS
#10 | 2013-07-25 ✅ Patent 9,717,803 granted on 2017-08-01Enzymatic conjugation of polypeptides
#11 | 2012-12-06 ✅ Patent 8,715,667 granted on 2014-05-06Methods of treating patients having TLR3-positive cancer
#12 | 2012-03-15 ✅ Patent 9,181,341 granted on 2015-11-10Anti-KIR3D antibodies
#13 | 2012-02-09 ✅ Patent 9,388,246 granted on 2016-07-12TLR3 binding agents
#14 | 2011-10-06 ✅ Patent 8,735,624 granted on 2014-05-27Polymorphic form of CHDMAPP, method of preparation thereof, and pharmaceutical composition comprising same
#15 | 2011-09-01 ✅ Patent 8,273,541 granted on 2012-09-25Compositions and methods for detecting TLR3
#16 | 2011-01-13 ✅ Patent 9,090,876 granted on 2015-07-28Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
#17 | 2010-11-18Class of Gamma Delta T Cells Activators and Use Thereof
#18 | 2009-03-26 ✅ Patent 8,119,775 granted on 2012-02-21Human anti-KIR antibodies
#19 | 2008-12-04Phosphoantigen Salts Of Organic Bases And Methods For Their Crystallization
#20 | 2008-11-06 ✅ Patent 9,447,185 granted on 2016-09-20Compositions and methods for treating proliferative disorders
#21 | 2006-11-02 ✅ Patent 7,279,291 granted on 2007-10-09Polypeptides having a triggering NK activity and biological applications
#22 | 2006-02-09 ✅ Patent 7,399,756 granted on 2008-07-15Organo-phosphorous compounds for activating gamma/delta T cells
#23 | 2005-10-06 ✅ Patent 7,517,966 granted on 2009-04-14Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
#24 | 2005-07-21 ✅ Patent 7,138,243 granted on 2006-11-21NTB-A, a surface molecule involved in natural killer cells activity
#25 | 2005-02-17 ✅ Patent 7,803,376 granted on 2010-09-28Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
Also check out INNATE PHARMA's (Marseille, France) applicant profile with 21 patent applications submitted.
31607 ⎘